Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.62 |
| ▸ | LTA4H | P09960 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.55 |
| ▸ | IDH1 | O75874 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | EDNRA | P25101 | 1/20 | 0.49 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.49 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14030856 | 1.00 | ACHE (0.62) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL13020521 | 0.94 | ACHE (0.56) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL13020514 | 0.94 | ACHE (0.56) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL13801587 | 0.94 | ACHE (0.56) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL14826542 | 0.94 | ACHE (0.56) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL13020525 | 0.94 | ACHE (0.56) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL13508238 | 0.94 | ACHE (0.56) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL13020524 | 0.94 | ACHE (0.56) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL3409810 | 0.94 | ACHE (0.71) | ACHELTA4HMAPTMAPK1L3MBTL1 | |
| SCHEMBL22451382 | 0.91 | LTA4H (0.71) | LTA4HMAOBIDH1CYP17A1SAE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE48156-E1 | Electronic device comprising an organic semiconducting material | NOVALED GMBH (DE) | 2020-08-11 | — | — | US | disclosed |
| US-9923148-B2 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2018-03-20 | — | — | US | disclosed |
| US-20170194568-A9 | Electroluminescent Device | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194568-A9 | Electroluminescent Device | DPYD, PNPO, TYMP | ACHE 325/4885LTA4H 2774/4885MAPT 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.